News

Using the Power of Social Media to Support the LRF Mission

In our increasingly interconnected world, people are using social media to support nonprofits—how can you make the biggest impact? When the first-ever telethon was hosted in 1949, the idea of pledging charitable donations over the phone was new but caught…

Playing the Long Game in Lymphoma Research

Playing the long game is not a new concept for Lymphoma Research Foundation Grantee and Scientific Advisory Board (SAB) member Ari Melnick, MD, of NewYork-Presbyterian/Weill Cornell Medicine. Lymphoma research is not a field for those looking for instant gratification, but Dr. Melnick has never taken a sprinter’s approach to finding cures for lymphoma. He is more of a marathoner.

Understanding Cancer-Related Financial Toxicity

Understanding Cancer-Related Financial Toxicity Cancer is one of the costliest conditions to treat today in the United States. With outcomes among patients with lymphoma improving, managing costs related to the diagnosis and treatment of their disease is a major concern.…

Lymphoma Research Foundation Debuts New Publication: Pulse

The Lymphoma Research Foundation is proud to launch its new flagship publication, Pulse.  Published quarterly, Pulse provides the latest updates on the Foundation and its focus on lymphoma and chronic lymphocytic leukemia (CLL) research, awareness and education. Pulse will also…

LRF Advocates for Patient Access to Cellular Therapies

On November 2, 2019, the Lymphoma Research Foundation sent a letter to Donald Thompson, Director, Division of Acute Care at the Centers for Medicare and Medicaid Services requesting for MS-DRG reclassification for certain cases involving the use of chimeric antigen receptor T-cell (CAR T-cell) therapies.